Report cover image

Active Pharmaceutical Ingredients Industry in India (2025 – 2030)

Publisher Netscribes (India) Pvt. Ltd.
Published Mar 01, 2025
Length 82 Pages
SKU # NBS20462254

Description

Market insights:

The market for Active Pharmaceutical Ingredients (API) in India includes the sourcing of raw materials and production, research and development, and supply of APIs to pharmaceutical companies globally.

In 2023, the active pharmaceutical ingredient (API) industry in India was valued at INR 1076.15 Bn. It is expected to reach INR 1826.53 Bn by 2030, expanding at a compound annual growth rate (CAGR) of ~8.26% during the 2025 – 2030 period. India is a leading supplier of generics, driving the demand for APIs both domestically and globally. India exports around 50% of its APIs to developed markets, including the US and Europe.

The shift toward self-reliance in pharmaceutical manufacturing and the push for compliance with quality standards, such as GMP certifications, are strengthening India’s position as a global leader in API production.

Market drivers:

As nations aim to lessen dependence on China for API sourcing, India's well-established manufacturing abilities make it a significant alternative supplier globally.

As global supply chains evolve, India has ramped up its API exports, especially to high-demand regions such as the US and Europe, supporting industry expansion.

Market trends:

With international markets enforcing stricter regulations, Indian API manufacturers are focusing on quality control and compliance with GMP (Good Manufacturing Practices) to sustain their competitive edge.

To address changing regulatory requirements, Indian firms are investing in improved infrastructure, advanced technologies, and a skilled workforce to maintain consistent product quality and compliance.

Table of Contents

82 Pages
Chapter 1: Executive Summary
Chapter 2: Socio-Economic Indicators
Chapter 3: Introduction
3.1. Market definition and structure
Chapter 4: Market Overview
4.1. API Industry in India – An Overview
4.2. India's Category-wise Share of Exports (2023 – 2024)
4.3. Country-wise Share of Drugs, Pharmaceuticals, and Fine-chemicals Exports in India (2023 – 2024)
4.4. Drug and Pharmaceutical Exports’ Trend in India (in INR Bn)
Chapter 5: Market Influencers
5.1. Market drivers
5.2. Market challenges
Chapter 6: Market Trends
6.1. Key Market Trends
Chapter 7: Government Initiatives
7.1. Favorable Government Initiatives
Chapter 8: Trade Analysis
8.1. Trade Analysis
Chapter 9: Competitive Landscape
9.1. Aurobindo Pharma Limited
Company information
Business description
Products/Services
Key people
Financial snapshot
Key ratios
Key financial performance indicators
Key business segments
Key geographic segments
Note: Financial data and segment-wise data is available only for public companies
9.2. Divi's Laboratories Limited
9.3. Dr. Reddy's Laboratories Limited
9.4. GlaxoSmithKline Pharmaceuticals Limited
9.5. Lupin Limited
9.6. Novartis India Limited
9.7. Pfizer Limited
9.8. Sanofi India Limited
9.9. Sun Pharmaceutical Industries Limited
9.10. Boehringer Ingelheim India Private Limited
Chapter 10: Recent Developments
10.1. Key Recent Developments
Chapter 11: Appendix
11.1. About Netscribes
11.2. Research methodology
11.3. Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us